uroporphyrin i has been researched along with Congenital Erythropoietic Porphyria in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Azuero-Dajud, R; Bragazzi Cunha, J; Elenbaas, JS; Ferguson, AC; Griffin, MS; Kuo, N; Lentz, SI; Maitra, D; Omary, MB; Shavit, JA | 1 |
| Costet, P; Daniel, JY; de Verneuil, H; Dubus, P; Ged, C; Lalanne, M; Lamrissi-Garcia, I; Mazurier, F; Mendez, M; Moreau-Gaudry, F; Robert, E | 1 |
| Calvas, P; Colombies, P; De Verneuil, H; Ged, C; Hombrados, I; Moreau-Gaudry, F; Taine, L | 1 |
3 other study(ies) available for uroporphyrin i and Congenital Erythropoietic Porphyria
| Article | Year |
|---|---|
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models.
Topics: Acitretin; Animals; Bone and Bones; Bone Development; Cell Line; Disease Models, Animal; Porphyria, Erythropoietic; Uroporphyrins; Zebrafish | 2021 |
A knock-in mouse model of congenital erythropoietic porphyria.
Topics: Amino Acid Substitution; Animals; Bone Marrow Transplantation; Disease Models, Animal; Genetic Therapy; Mice; Mice, Transgenic; Mutation, Missense; Porphyria, Erythropoietic; Uroporphyrinogen III Synthetase; Uroporphyrins | 2006 |
Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis.
Topics: Amniotic Fluid; DNA Mutational Analysis; Female; Fetal Diseases; Homozygote; Humans; Mutation; Porphyria, Erythropoietic; Pregnancy; Prenatal Diagnosis; Uroporphyrinogen III Synthetase; Uroporphyrins | 1996 |